Tracking dendritic cells in vivo in patients with multiple myeloma.

被引：0
|
作者：
Wall, DM
Thompson, M
Mileshkin, L
Loveland, B
Coverdale, J
Xing, PX
Bartholeyns, J
Hicks, R
Prince, M
机构：
[1] Peter MacCallum Canc Ctr, Ctr Blood Cell Therapies, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Ctr, PET Ctr, Melbourne, Vic, Australia
[3] Austin Res Inst, Heidelberg, Vic, Australia
[4] IDM SA, Paris, France
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3469
引用
收藏
页码：968A / 968A
页数：1
相关论文
共 50 条
  • [1] In vivo tracking of dendritic cell therapy in patients with multiple myeloma.
    Wall, DM
    Mileshkin, LR
    Prince, HM
    Loveland, BE
    Thompson, M
    Coverdale, J
    Wong, J
    Xing, PX
    Taylor, R
    Hicks, RJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 180S - 180S
  • [2] In vivo tracking of dendritic cells in patients with multiple myeloma
    Prince, H. Miles
    Wall, Dominic M.
    Ritchie, David
    Honemann, Dirk
    Harrrison, Simon
    Quach, Hang
    Thompson, Mick
    Hicks, Rodney
    Lau, Eddie
    Davison, Jill
    Loudovaris, Maureen
    Moloney, Jude
    Loveland, Bruce
    Bartholeyns, Jacques
    Katsifis, Andrew
    Mileshkin, Linda
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (02) : 166 - 179
  • [3] Ex vivo generation and function of dendritic cells in multiple myeloma.
    Pfeiffer, S
    Samson, D
    Apperley, J
    Gooding, R
    IMMUNOLOGY, 1996, 89 : II363 - II363
  • [4] Ex vivo generation and function of dendritic cells in multiple myeloma.
    Pfeiffer, S
    Samson, D
    Apperley, J
    Gooding, R
    BLOOD, 1996, 88 (10) : 1556 - 1556
  • [5] A study of in vivo tracking of MUC-1 pulsed dendritic cells in patients with multiple myeloma
    Mileshkin, LR
    Wall, DM
    Loveland, BE
    Thompson, M
    Coverdale, J
    Wong, J
    Xing, PX
    Taylor, RR
    Hicks, RJ
    Prince, HM
    JOURNAL OF IMMUNOTHERAPY, 2004, 27 (06) : S27 - S27
  • [6] Monitoring of dendritic cell numbers in patients during the treatment of multiple myeloma.
    Kovarova, L
    Hajek, R
    Svobodnik, A
    Penka, M
    Mayer, J
    BLOOD, 2005, 106 (11) : 356B - 356B
  • [7] Multiple Myeloma/Dendritic cell fusions as a vaccination strategy for myeloma.
    Raje, N
    Hideshima, T
    Teoh, G
    Shima, Y
    Davies, FE
    Chauhan, D
    Treon, SP
    Tai, YT
    Schlossman, RL
    Avigan, D
    Gong, J
    Kufe, DW
    Anderson, KC
    BLOOD, 1999, 94 (10) : 123A - 123A
  • [8] Ex vivo expansion of cytotoxic effector cells in patients with myeloma.
    Wu, JY
    Waugh, MG
    Meehan, KR
    BLOOD, 2003, 102 (11) : 422B - 423B
  • [9] Effect of ibandronate in an in vivo model of multiple myeloma.
    Cruz, JC
    Alsina, M
    Anderson, J
    Mundy, GR
    Yoneda, T
    Roodman, GD
    BLOOD, 1998, 92 (10) : 275B - 275B
  • [10] Dendritic cell based idiotype vaccination in multiple myeloma.
    Bohlen, H
    Titzer, S
    Christensen, O
    Manzke, O
    Wolf, J
    Thiele, J
    Diehl, V
    Tesch, H
    BLOOD, 1997, 90 (10) : 2577 - 2577
12345